HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300 | -75.6% | 291,300 | -72.5% | 0.00% | -50.0% |
| Q2 2023 | $1,229 | -28.7% | 1,059,100 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $1,723 | +111.2% | 1,140,836 | +249.4% | 0.00% | +100.0% |
| Q4 2022 | $816 | -100.0% | 326,500 | +100.8% | 0.00% | -66.7% |
| Q1 2021 | $2,636,000 | +31.9% | 162,600 | +20.6% | 0.00% | +50.0% |
| Q3 2020 | $1,998,000 | -43.4% | 134,800 | -43.8% | 0.00% | -33.3% |
| Q2 2020 | $3,527,000 | -71.4% | 239,800 | -77.2% | 0.00% | -75.0% |
| Q1 2020 | $12,349,000 | +190.3% | 1,051,892 | +481.2% | 0.01% | +300.0% |
| Q4 2019 | $4,254,000 | +134.9% | 181,000 | +85.8% | 0.00% | +50.0% |
| Q2 2019 | $1,811,000 | -57.3% | 97,400 | -27.4% | 0.00% | -50.0% |
| Q3 2018 | $4,244,000 | -72.2% | 134,100 | -65.8% | 0.00% | -50.0% |
| Q2 2018 | $15,249,000 | +956.0% | 392,500 | +391.9% | 0.01% | +300.0% |
| Q4 2017 | $1,444,000 | -3.7% | 79,800 | +65.9% | 0.00% | -33.3% |
| Q2 2015 | $1,499,000 | – | 48,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |